-
2
-
-
33644537268
-
'Rescue' therapies for the management of Helicobacter pylori infection
-
Di Mario F, Cavallaro LG, Scarpignato C. 'Rescue' therapies for the management of Helicobacter pylori infection. Dig Dis 2006;24:113-130.
-
(2006)
Dig Dis
, vol.24
, pp. 113-130
-
-
Di Mario, F.1
Cavallaro, L.G.2
Scarpignato, C.3
-
4
-
-
23844454901
-
Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents - An evidence-based evaluation
-
Bourke B, Ceponis P, Chiba N, Czinn S, Ferraro R, Fischbach L, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents - an evidence-based evaluation. Can J Gastroenterol 2005;19:399-408.
-
(2005)
Can J Gastroenterol
, vol.19
, pp. 399-408
-
-
Bourke, B.1
Ceponis, P.2
Chiba, N.3
Czinn, S.4
Ferraro, R.5
Fischbach, L.6
-
6
-
-
33847010115
-
Results from the pediatric European register for treatment of Helicobacter pylori (PERTH)
-
Oderda G, Shcherbakov P, Bontems P, Urruzuna P, Romano C, Gottrand F, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 2007;12:150-156.
-
(2007)
Helicobacter
, vol.12
, pp. 150-156
-
-
Oderda, G.1
Shcherbakov, P.2
Bontems, P.3
Urruzuna, P.4
Romano, C.5
Gottrand, F.6
-
7
-
-
33750545145
-
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: A large prospective single-center randomized study
-
Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, et al. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: A large prospective single-center randomized study. Helicobacter 2006;11:562-568.
-
(2006)
Helicobacter
, vol.11
, pp. 562-568
-
-
Paoluzi, P.1
Iacopini, F.2
Crispino, P.3
Nardi, F.4
Bella, A.5
Rivera, M.6
-
8
-
-
34147206129
-
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: The HYPER Study
-
Zagari RM, Bianchi-Porro G, Fiocca R, Gasbarrini G, Roda E, Bazzoli F. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: The HYPER Study. Gut 2007;56:475-479.
-
(2007)
Gut
, vol.56
, pp. 475-479
-
-
Zagari, R.M.1
Bianchi-Porro, G.2
Fiocca, R.3
Gasbarrini, G.4
Roda, E.5
Bazzoli, F.6
-
9
-
-
34247844165
-
Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report
-
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut 2007;56:772-781.
-
(2007)
Gut
, vol.56
, pp. 772-781
-
-
Malfertheiner, P.1
Megraud, F.2
O'Morain, C.3
Bazzoli, F.4
El-Omar, E.5
Graham, D.6
-
10
-
-
34250852952
-
A meta-analysis of the success rate of Helicobacter pylori therapy in Canada
-
Rodgers C, van Zanten SV. A meta-analysis of the success rate of Helicobacter pylori therapy in Canada. Can J Gastroenterol 2007;21:295-300.
-
(2007)
Can J Gastroenterol
, vol.21
, pp. 295-300
-
-
Rodgers, C.1
van Zanten, S.V.2
-
11
-
-
0034847354
-
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy
-
Magaret N, Burm M, Faigel D, Kelly C, Peterson W, Fennerty MB. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Dig Dis 2001;19:174-178.
-
(2001)
Dig Dis
, vol.19
, pp. 174-178
-
-
Magaret, N.1
Burm, M.2
Faigel, D.3
Kelly, C.4
Peterson, W.5
Fennerty, M.B.6
-
12
-
-
0013575179
-
The exclusion criteria were as follows classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994
-
Dixon MF, Genta RM, Yardley JH, Correa P. The exclusion criteria were as follows classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181.
-
(1996)
Am J Surg Pathol
, vol.20
, pp. 1161-1181
-
-
Dixon, M.F.1
Genta, R.M.2
Yardley, J.H.3
Correa, P.4
-
13
-
-
0033664804
-
Helicobacter pylori infection in children: Recommendations for diagnosis and treatment
-
Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, et al. Helicobacter pylori infection in children: Recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:4907.
-
(2000)
J Pediatr Gastroenterol Nutr
, vol.31
, pp. 4907
-
-
Gold, B.D.1
Colletti, R.B.2
Abbott, M.3
Czinn, S.J.4
Elitsur, Y.5
Hassall, E.6
-
15
-
-
0034094599
-
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection
-
Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:603-609.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 603-609
-
-
Calvet, X.1
Garcia, N.2
Lopez, T.3
Gisbert, J.P.4
Gene, E.5
Roque, M.6
-
16
-
-
25844490055
-
Treatment of Helicobacter pylori
-
Bytzer P, O'Morain C. Treatment of Helicobacter pylori. Helicobacter 2005;10:40-46.
-
(2005)
Helicobacter
, vol.10
, pp. 40-46
-
-
Bytzer, P.1
O'Morain, C.2
-
17
-
-
0035120425
-
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
-
Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol 2001;96:359-366.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 359-366
-
-
Maconi, G.1
Parente, F.2
Russo, A.3
Vago, L.4
Imbesi, V.5
Bianchi Porro, G.6
-
18
-
-
0030153688
-
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori
-
Moayyedi P, Langworthy H, Shanahan K, Tompkins DS, Dixon MF, Chalmers DM, et al. Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. Helicobacter 1996;1:71-74.
-
(1996)
Helicobacter
, vol.1
, pp. 71-74
-
-
Moayyedi, P.1
Langworthy, H.2
Shanahan, K.3
Tompkins, D.S.4
Dixon, M.F.5
Chalmers, D.M.6
-
19
-
-
0033791058
-
A systematic review of Helicobacter pylori eradication treatment schedules in children
-
Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther 2000;14:1-8.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 1-8
-
-
Oderda, G.1
Rapa, A.2
Bona, G.3
-
20
-
-
0031932458
-
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
-
Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
-
(1998)
J Gastroenterol Hepatol
, vol.13
, pp. 1-12
-
-
Lam, S.K.1
Talley, N.J.2
-
21
-
-
47349088553
-
Detection of Helicobacter pylori and clarithromycin resistance by real-time PCR in children
-
16th European Congress of Clinical Microbiology and Infectious Diseases. April 1-4, Nice, France. Abstract P
-
Akyon Y, Tuncer S, Demir H, Misirlioglu M, Usta Y. Detection of Helicobacter pylori and clarithromycin resistance by real-time PCR in children. 16th European Congress of Clinical Microbiology and Infectious Diseases. April 1-4, 2006, Nice, France. Abstract P 1449.
-
(2006)
, pp. 1449
-
-
Akyon, Y.1
Tuncer, S.2
Demir, H.3
Misirlioglu, M.4
Usta, Y.5
-
22
-
-
33748441770
-
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
-
Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, et al. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Helicobacter 2006;11:436-440.
-
(2006)
Helicobacter
, vol.11
, pp. 436-440
-
-
Murakami, K.1
Okimoto, T.2
Kodama, M.3
Sato, R.4
Miyajima, H.5
Ono, M.6
-
23
-
-
1342313826
-
Review article: Treatment of Helicobacter pylori infection and factors influencing eradication
-
Qasim A, O'Morain CA. Review article: Treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther 2002;16:24-30.
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 24-30
-
-
Qasim, A.1
O'Morain, C.A.2
-
25
-
-
0035999136
-
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor based triple therapies fail
-
Gisbert JP, Pajares JM. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor based triple therapies fail. Aliment Pharmacol Ther 2002;16:1047-1057.
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1047-1057
-
-
Gisbert, J.P.1
Pajares, J.M.2
-
26
-
-
11144355619
-
High efficacy of 1-week doxycycline-and amoxicillinbased quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection
-
Cammarota G, Martino A, Pirozzi G, Cianci R, Branca G, Nista EC, et al. High efficacy of 1-week doxycycline-and amoxicillinbased quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment Pharmacol Ther 2004;19:789-795.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 789-795
-
-
Cammarota, G.1
Martino, A.2
Pirozzi, G.3
Cianci, R.4
Branca, G.5
Nista, E.C.6
-
27
-
-
10644278136
-
Meta-analysis: The efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies
-
Fischbach LA, Van Zanten SV, Dickason J. Meta-analysis: The efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004;20:1071-1082.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 1071-1082
-
-
Fischbach, L.A.1
Van Zanten, S.V.2
Dickason, J.3
-
28
-
-
0038528405
-
Triple vs. quadruple therapy for treating Helicobacter pylori infection: A meta-analysis
-
Gene E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: A meta-analysis. Aliment Pharmacol Ther 2003;17:1137-1143.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 1137-1143
-
-
Gene, E.1
Calvet, X.2
Azagra, R.3
Gisbert, J.P.4
-
29
-
-
33645297668
-
Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly
-
Dore MP, Maragkoudakis E, Pironti A, Tadeu V, Tedde R, Realdi G, et al. Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly. Helicobacter 2006;11:52-55.
-
(2006)
Helicobacter
, vol.11
, pp. 52-55
-
-
Dore, M.P.1
Maragkoudakis, E.2
Pironti, A.3
Tadeu, V.4
Tedde, R.5
Realdi, G.6
-
30
-
-
2642514243
-
Helicobacter pylori infection in Turkish children: Comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication
-
Ozcay F, Kocak N, Temizel IN, Demir H, Ozen H, Yuce A, et al. Helicobacter pylori infection in Turkish children: Comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication. Helicobacter 2004;9:242-248.
-
(2004)
Helicobacter
, vol.9
, pp. 242-248
-
-
Ozcay, F.1
Kocak, N.2
Temizel, I.N.3
Demir, H.4
Ozen, H.5
Yuce, A.6
|